期刊文献+

GnRH激动剂对人卵巢癌裸鼠移植瘤抑制作用及不良反应的研究

The inhibition the effect of gonadotropin releasing hormone agonist on the growth of transplanted human epithelium ovarian cancer in nude mice and its side effects
下载PDF
导出
摘要 目的研究GnRH激动剂对人卵巢癌裸鼠移植瘤抑制作用及副作用。方法将人卵巢癌细胞OVCAR3注射入裸鼠腹腔内,构建移植瘤模型。将裸鼠随机分为3组,OVCAR3对照组、低剂量曲普瑞林组(75μg)和高剂量曲普瑞林组(150μg)。镜下观察曲普瑞林对全身及腹腔各脏器的毒副作用并测定对内分泌的影响。结果高剂量曲普瑞林组腹腔移植瘤个数和体积最少(P<0.05)。曲普瑞林对脏器无明显不良反应,高剂量曲普瑞林组血清雌激素明显低于OVCAR3对照组和低剂量曲普瑞林组(P<0.05),血清促卵泡素明显高于OVCAR3对照组和低剂量曲普瑞林组(P<0.05)。结论 GnRH激动剂可抑制人卵巢癌裸鼠移植瘤生长,不良反应是引起雌激素缺乏,促卵泡素增多。 Objective To observe the effect of gonadotropin releasing hormone agonist (triptorelin) on the growth of transplanted human epithelium ovarian cancer in nude mice and its side effects. Methods The transplantation tumor models were established by injecting OVCAR3 cells into the peritoneal cavity of nude mice, then the mice were randomly divided into three groups : control group, low-dose triptorelin group (75μg) and high-dose triptorelin group(150μg). The effect of triptorelin on endocrine and its side effects on the organs of abdominal cavity and all over the body of the mice were observed under light microscope. Results The high-dose triptorelin could obviously inhibit the growth of transplanted human epithelium ovarian cancer in nude mice, and the number and size of transplantation tumor in abdominal cavity in high-dose triptorelin group were the least among the three groups ( P 〈 0.05 ). Triptorelin had no obvious side effects on the organs of the nude mice, and the levels of serum estrogens in high-dose triptorelin group were significantly lower than those in control group and low-dose triptorelin group ( P 〈 0.05), however, the levels of serum follicle stimulating hormone were significantly higher than those in control group and low-dose triptorelin group ( P 〈 0.05). Conclusion The gonadotropin releasing hormone agonist can inhibit the growth of transplanted human epithelium ovarian cancer in nude mice, with the side effects of lack of estrogen and increase of follicle stimulating hormone.
机构地区 河北省人民医院
出处 《河北医药》 CAS 2011年第23期3541-3543,共3页 Hebei Medical Journal
关键词 人卵巢癌 裸鼠 移植瘤 促性腺激素释放激素激动剂 曲普瑞林 雌二醇 卵泡刺激素 human ovarian cancer nude mice transplantation tumor gonadotropin releasing hormone agonist triptorelin estradiol follicle stimulating hormone
  • 相关文献

参考文献11

  • 1孙秀凤,刘洪彬.肿瘤五项标志物联合检测对诊断卵巢癌的临床应用价值[J].河北医药,2009,31(12):1517-1518. 被引量:18
  • 2Chien CH, Lee CY, Chang TC, et al. Detection of gonadotropin-releasing hormone receptor and its mRNA in primary human epithelial ovarian cancers. Int J Gynecol Cancer, 2004,14:451-458.
  • 3Choi JH, Choi KC, Auersperg N, et al. Differential regulation Of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonado- tropins in human immortalized ovarian surface epithelium and ovarian cancer ceils. Endocr Relat Cancer, 2006,13 : 641-651.
  • 4Grundker C, Gunthert AR, Millar RP, et al. Expression of gonadotropin- releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab,2002,87 : 1427-1430.
  • 5Eicke N,Gunthert AR,Emons G,et al. GnRH-II agonist ^[D-Lys6] GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endom- etrial and ovarian cancer cells. Int J Oncol,2006,29:1223-1229.
  • 6Nagy A, Schally AV: Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers. Biol Reprod,2005,73:851-859.
  • 7Lopez de Maturana R, Pawson AJ, Lu ZL et al. Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth:support for the concept of ligand-induced selective signaling. Mol Endocrinol,2008 ,22 : 1711-1722.
  • 8Marelli MM, Moretti RM, Januszkiewicz-Caulier J. Gonadotropin-releasing hormone (GnRH) receptors in tumors : a new rationale for the therapeuti- cal application of GnRH analogs in cancer patients? Curr Cancer Drug Targets ,2006,6:257-269.
  • 9Grundker C, Vlker P, Griesinger F, et al Antitumor effects of the cytotox- ic luteinizing hormone-releasing hormone analog AN-152 on human endo- metrial and ovarian cancers xenografted into nude mice. Am J Obstet Gynecol,2002 ,187 :528-537.
  • 10Schottelius M, Berger S, Poethko T, et al. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficien- cy. Bioconjug Chem ,2008,19 : 1256-1268.

二级参考文献4

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部